Cargando…
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma
Mantle cell lymphoma (MCL) is a phenotypically and genetically heterogeneous malignancy in which the genetic alterations determining clinical indications are not fully understood. Here, we performed a comprehensive whole-exome sequencing analysis of 152 primary samples derived from 134 MCL patients,...
Autores principales: | Yi, Shuhua, Yan, Yuting, Jin, Meiling, Bhattacharya, Supriyo, Wang, Yi, Wu, Yiming, Yang, Lu, Gine, Eva, Clot, Guillem, Chen, Lu, Yu, Ying, Zou, Dehui, Wang, Jun, Phan, An T., Cui, Rui, Li, Fei, Sun, Qi, Zhai, Qiongli, Wang, Tingyu, Yu, Zhen, Liu, Lanting, Liu, Wei, Lyv, Rui, Sui, Weiwei, Huang, Wenyang, Xiong, Wenjie, Wang, Huijun, Li, Chengwen, Xiao, Zhijian, Hao, Mu, Wang, Jianxiang, Cheng, Tao, Bea, Silvia, Herrera, Alex F., Danilov, Alexey, Campo, Elias, Ngo, Vu N., Qiu, Lugui, Wang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803323/ https://www.ncbi.nlm.nih.gov/pubmed/34882582 http://dx.doi.org/10.1172/JCI153283 |
Ejemplares similares
-
Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma
por: Li, Ru, et al.
Publicado: (2022) -
High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival
por: Yi, Shuhua, et al.
Publicado: (2015) -
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China
por: Yan, Yuting, et al.
Publicado: (2023) -
Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia
por: Xiong, Wenjie, et al.
Publicado: (2023) -
Cytogenetic aberrations of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia in Chinese patients
por: Xiong, Wenjie, et al.
Publicado: (2023)